Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Asthma drug from the garden center

14.09.2017

The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways. The plant itself is not exotic: it can be found in any well-stocked garden center. The study is published in the renowned journal Science Translational Medicine.

The coralberry is no outstanding beauty most of the year. This however changes in the winter months: it then forms striking, bright red berries, which make it a popular ornamental plant during this time.


The leaves of the coralberry (Ardisia crenata) contain the natural substance FR900359.

© Photo: Raphael Reher/Daniela Wenzel/Uni Bonn


Prof. Dr. Daniela Wenzel, Alexander Seidinger, Annika Simon and Dr. Michaela Matthey (from left).

(c) Photo: Katharina Wislsperger/Ukom-UKB

Nevertheless, the scientists involved in the study are interested in the plant for another reason: the leaves of the coralberry contain a substance with the cryptic name FR900359. It is assumed that this could be suitable as a medication against certain diseases, despite the fact that Ardisia crenata (its botanical name) has so far been largely disregarded by science.

Researchers at the Institutes of Physiology I, Pharmaceutical Biology and Pharmaceutical Chemistry at the University of Bonn, together with asthma specialists from Nottingham (United Kingdom), have now published a study that could change this.

They found that FR900359 is very effective at preventing the bronchial muscles from contracting. Asthmatics regularly suffer from these pronounced contractions preventing adequate ventilation of the lungs. The resulting shortness of breath can be life-threatening.

More effective than common medicines

The new compound relieves these spasms – and is supposedly more effective and has a more prolonged action than the most common asthma drug salbutamol. “However, we have so far only tested the substance in asthmatic mice,” explains junior professor Dr. Daniela Wenzel. Wenzel is doing research in respiratory diseases at the Institute of Physiology I at the University of Bonn; she was the leader of the study.

The idea to test FR900359 came from the Institute of Pharmaceutical Biology: there, the scientists managed to isolate and characterize the active pharmaceutical substance from the leaves of the coralberry. “This compound inhibits critical signaling molecules in our cells, the Gq proteins,” explains Wenzel. Gq proteins exert key functions in many processes in the body – including control of the airway tone.

Normally, interaction of various signaling pathways induces narrowing of the airways. Inhibition of individual signaling pathways can reduce the contraction of the respiratory tract. However, this does not make it possible to completely prevent such contractions in patients with severe asthma. The various contracting signals converge on Gq proteins and trigger airway spasm. “When we inhibit the activation of Gq proteins with FR900359, we achieve a much greater effect,” emphasizes Dr. Michaela Matthey from the Institute of Physiology I.

This worked exceptionally well in asthmatic mice in the study. “We were able to prevent the animals from reacting to allergens such as house dust mite with a narrowing of the bronchia,” Wenzel is pleased to report. There were hardly any side effects, as the active pharmaceutical ingredient could be applied via inhalation to the respiratory tract and thus only reached the systemic circulation in small quantities.

However, it is not known whether the substance is also suitable for use in people. Although the scientists have already been able to show that human bronchial muscle cells in a petri dish and isolated human airways react in a similarly promising manner, further tests, which could take years, are required prior to its application in people.

Nevertheless, the work is already a great success. This is no coincidence: the German Research Foundation (DFG) funds the research group “G protein signal cascades: creating new pharmaceutical concepts with molecular probes and active pharmaceutical ingredients” at the University of Bonn.

The aim is to pharmaceutically influence central signaling molecules such as the Gq proteins to identify novel substances for the treatment of certain diseases. Physiologists and pharmacists at the University collaborate closely within the research group; the current study is the result of this successful scientific interaction.

Publication: Michaela Matthey, Richard Roberts, Alexander Seidinger, Annika Simon, Ralf Schröder, Markus Kuschak, Suvi Annala, Gabriele M König, Christa E Müller, Ian P Hall, Evi Kostenis, Bernd K Fleischmann, Daniela Wenzel: Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma; Science Translational Medicine; DOI: 10.1126/scitranslmed.aag2288

Contact:

Junior professor Dr. Daniela Wenzel
Institute of Physiology I
Life & Brain Center
Faculty of Medicine
University of Bonn
Tel. +49 (0)228/6885-216
E-mail: dwenzel@uni-bonn.de

Prof. Bernd. K. Fleischmann
Institute of Physiology I
Life & Brain Center
Faculty of Medicine
University of Bonn
Tel. +49 (0)228/6885-200
E-mail: bernd.fleischmann@uni-bonn.de

Johannes Seiler | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-bonn.de

Further reports about: Asthma Biology Physiology airway proteins respiratory tract signaling molecules

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Regensburg physicists watch electron transfer in a single molecule

For the first time, an international team of scientists based in Regensburg, Germany, has recorded the orbitals of single molecules in different charge states in a novel type of microscopy. The research findings are published under the title “Mapping orbital changes upon electron transfer with tunneling microscopy on insulators” in the prestigious journal “Nature”.

The building blocks of matter surrounding us are atoms and molecules. The properties of that matter, however, are often not set by these building blocks...

Im Focus: University of Konstanz gains new insights into the recent development of the human immune system

Scientists at the University of Konstanz identify fierce competition between the human immune system and bacterial pathogens

Cell biologists from the University of Konstanz shed light on a recent evolutionary process in the human immune system and publish their findings in the...

Im Focus: Transformation through Light

Laser physicists have taken snapshots of carbon molecules C₆₀ showing how they transform in intense infrared light

When carbon molecules C₆₀ are exposed to an intense infrared light, they change their ball-like structure to a more elongated version. This has now been...

Im Focus: Famous “sandpile model” shown to move like a traveling sand dune

Researchers at IST Austria find new property of important physical model. Results published in PNAS

The so-called Abelian sandpile model has been studied by scientists for more than 30 years to better understand a physical phenomenon called self-organized...

Im Focus: Cryo-force spectroscopy reveals the mechanical properties of DNA components

Physicists from the University of Basel have developed a new method to examine the elasticity and binding properties of DNA molecules on a surface at extremely low temperatures. With a combination of cryo-force spectroscopy and computer simulations, they were able to show that DNA molecules behave like a chain of small coil springs. The researchers reported their findings in Nature Communications.

DNA is not only a popular research topic because it contains the blueprint for life – it can also be used to produce tiny components for technical applications.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Global Legal Hackathon at HAW Hamburg

11.02.2019 | Event News

The world of quantum chemistry meets in Heidelberg

30.01.2019 | Event News

Our digital society in 2040

16.01.2019 | Event News

 
Latest News

Gravitational waves will settle cosmic conundrum

15.02.2019 | Physics and Astronomy

Spintronics by 'straintronics'

15.02.2019 | Physics and Astronomy

Platinum nanoparticles for selective treatment of liver cancer cells

15.02.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>